NGAL_HUMAN - dbPTM
NGAL_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NGAL_HUMAN
UniProt AC P80188
Protein Name Neutrophil gelatinase-associated lipocalin
Gene Name LCN2
Organism Homo sapiens (Human).
Sequence Length 198
Subcellular Localization Secreted . Upon binding to the SLC22A17 (24p3R) receptor, it is internalized.
Protein Description Iron-trafficking protein involved in multiple processes such as apoptosis, innate immunity and renal development. Binds iron through association with 2,5-dihydroxybenzoic acid (2,5-DHBA), a siderophore that shares structural similarities with bacterial enterobactin, and delivers or removes iron from the cell, depending on the context. Iron-bound form (holo-24p3) is internalized following binding to the SLC22A17 (24p3R) receptor, leading to release of iron and subsequent increase of intracellular iron concentration. In contrast, association of the iron-free form (apo-24p3) with the SLC22A17 (24p3R) receptor is followed by association with an intracellular siderophore, iron chelation and iron transfer to the extracellular medium, thereby reducing intracellular iron concentration. Involved in apoptosis due to interleukin-3 (IL3) deprivation: iron-loaded form increases intracellular iron concentration without promoting apoptosis, while iron-free form decreases intracellular iron levels, inducing expression of the proapoptotic protein BCL2L11/BIM, resulting in apoptosis. Involved in innate immunity, possibly by sequestrating iron, leading to limit bacterial growth..
Protein Sequence MPLGLLWLGLALLGALHAQAQDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGCQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
21Pyrrolidone_carboxylic_acidGALHAQAQDSTSDLI
HHHHHHHCCCCCCCC
32.867683678
21Pyrrolidone_carboxylic_acidGALHAQAQDSTSDLI
HHHHHHHCCCCCCCC
32.86-
21Pyrrolidone_carboxylic_acidGALHAQAQDSTSDLI
HHHHHHHCCCCCCCC
32.867683678
23PhosphorylationLHAQAQDSTSDLIPA
HHHHHCCCCCCCCCC
20.1024505115
72PhosphorylationDKDPQKMYATIYELK
CCCHHHHEEEEEECC
13.97-
76PhosphorylationQKMYATIYELKEDKS
HHHEEEEEECCCCCC
15.74-
792-HydroxyisobutyrylationYATIYELKEDKSYNV
EEEEEECCCCCCCCE
52.51-
83PhosphorylationYELKEDKSYNVTSVL
EECCCCCCCCEEEEE
33.9723403867
84PhosphorylationELKEDKSYNVTSVLF
ECCCCCCCCEEEEEE
21.2823403867
85N-linked_GlycosylationLKEDKSYNVTSVLFR
CCCCCCCCEEEEEEE
37.3715084671
85N-linked_GlycosylationLKEDKSYNVTSVLFR
CCCCCCCCEEEEEEE
37.3715084671
87PhosphorylationEDKSYNVTSVLFRKK
CCCCCCEEEEEEEEC
14.9623403867
88PhosphorylationDKSYNVTSVLFRKKK
CCCCCEEEEEEEECC
16.7323403867
126PhosphorylationSYPGLTSYLVRVVST
CCCCCEEEEEEEEEC
12.18-
132PhosphorylationSYLVRVVSTNYNQHA
EEEEEEEECCCCCEE
14.2130631047
133PhosphorylationYLVRVVSTNYNQHAM
EEEEEEECCCCCEEE
30.07-
154AcetylationSQNREYFKITLYGRT
HHCCCEEEEEEECCH
33.6025038526

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of NGAL_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NGAL_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NGAL_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NGAL_HUMANLCN2physical
7683678

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NGAL_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-85, AND MASS SPECTROMETRY.
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry.";
Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.;
J. Proteome Res. 5:1493-1503(2006).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-85, AND MASS SPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-85, AND MASS SPECTROMETRY.
"A proteomic analysis of human bile.";
Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.;
Mol. Cell. Proteomics 3:715-728(2004).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-85, AND MASS SPECTROMETRY.
"Isolation and primary structure of NGAL, a novel protein associatedwith human neutrophil gelatinase.";
Kjeldsen L., Johnsen A.H., Sengelov H., Borregaard N.;
J. Biol. Chem. 268:10425-10432(1993).
Cited for: PROTEIN SEQUENCE OF 21-198.
Pyrrolidone carboxylic acid
ReferencePubMed
"Isolation and primary structure of NGAL, a novel protein associatedwith human neutrophil gelatinase.";
Kjeldsen L., Johnsen A.H., Sengelov H., Borregaard N.;
J. Biol. Chem. 268:10425-10432(1993).
Cited for: PROTEIN SEQUENCE OF 21-198.

TOP